Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma: A prospective database study

Annals of Surgery

Volumn 233, Issue 3, 2001, Pages 293-299

  Strasberg, Steven M ^a,b   Dehdashti, Farrokh ^a   Siegel, Barry A ^a   Drebin, Jeffrey A ^a   Linehan, David ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b 7308 West Pavillion Tower ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE;

ADULT; AGED; CANCER CELL; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; DATA BASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; LAPAROTOMY; LIVER METASTASIS; LIVER RESECTION; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; REVIEW; SURVIVAL RATE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT PLANNING;

AGED; CARCINOMA; COLORECTAL NEOPLASMS; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MISSOURI; NEOPLASM STAGING; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0035116019     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200103000-00001     Document Type: Review

References (29)

1. Hepatic metastases from colorectal carcinoma: Impact of surgical resection on the natural history
2. Determinants of survival in liver resection for colorectal secondaries
3. Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrences in 80 patients
4. Major hepatic resection for colorectal liver metastases
5. Resection of the liver for colorectal carcinoma metastases: A multi-institutional study of indications for resection
6. Resection of liver metastases in colorectal cancer: Competitive analysis of treatment results in synchronous versus metachronous metastases
7. One hundred patients with hepatic metastases from colorectal cancer treated by resection: Analysis of prognostic determinants
8. Hepatic resections for colorectal metastases: The Italian multicenter experience
9. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma
10. Liver resection for colorectal liver metastases
11. A study of prognostic factors for hepatic resection for colorectal metastases
12. Hepatic resection for metastases in colorectal carcinoma
13. Hepatic resection for metastatic colorectal cancer
14. Determinants of survival following hepatic resection for metastatic colorectal cancer
15. Resection of colorectal liver metastases: 25-year experience
16. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases
17. 18F]fluorodeoxyglucose in management of recurrent colorectal cancer
18. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: Correlation with histopathologic and CT findings
19. Staging recurrent metastatic colorectal carcinoma with PET
20. Detection of recurrent and metastatic colorectal cancer: Comparison of positron emission tomography and computed tomography
21. 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases
22. Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose in recurrent colorectal cancer
23. Positron emission tomography with F-18-fluorodeoxyglucose to evaluate the results of hepatic chemoembolization
24. 18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver
25. Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer
26. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer
27. Liver resection for metastatic colorectal cancer: Assessing the risk of occult irresectable disease
28. Superior staging of liver tumors with laparoscopy and laparoscopic ultrasound
29. FDG-PET evaluation of mucinous neoplasms: Correlation of FDG uptake with histopathologic features